Background--Gap junction channels made of Connexin37 (Cx37) are expressed by aortic endothelial and smooth muscle cells of hypertensive mice, as well as by the renin-secreting cells of kidneys.
V ascular gap junctions formed of connexins (Cx) 1 provide for communications between endothelial cells (EC), smooth muscle cells (SMC), and renin-secreting cells, which are required to control blood pressure (BP). [2] [3] [4] In the vasculature, EC predominantly express Cx37 and Cx40, [5] [6] [7] [8] [9] [10] whereas SMC mostly express Cx43 and Cx45, 6, 11, 12 and renin-secreting cells express Cx40 and Cx37. 2, 7, 9, [13] [14] [15] Various changes in the expression of these proteins have been documented in different models of vascular alterations, notably during chronic changes in BP. [2] [3] [4] Specifically, Cx43
has been reported to allow for the rapid diffusion of calciumdependent contraction waves between SMC, which ultimately control vasomotor tone, 16, 17 and we have documented a prominent role of Cx40 in renin-dependent hypertension. 13, 14, 18 This protein also interacts with endothelial nitric oxide synthase (eNOS) to increase the production of NO which, in turn, promotes the relaxation of SMC. 5, 19 Both renindependent and -independent models of chronic hypertension also induce the expression of Cx37 in vascular SMC 2, 6, 9 ; still the protein appears dispensable for the physiological control of renin expression and function. 7, 14, 15, 18 Thus, whether and how Cx37 contributes to control BP remains to be fully investigated.
To approach this question, we compared wild type (WT) and Cx37À/À mice after (1) an infusion of angiotensin II (Ang II) via osmotic mini-pumps; (2) induction of a renindependent hypertension, as provided by the 2-kidney, 1-clip (2K1C) surgical procedure; and (3) induction of a renin-independent model of hypertension, as provided by a N-nitro-L-arginine-methyl-ester (L-NAME) treatment. We further compared the aortas of these animals ex vivo, under basal conditions and following an exposure to Ang II. Here, we show that loss of Cx37 partially protects mice against the development of Ang II-dependent hypertension, but not against the hypertension induced by L-NAME. We further document that the lower increase in BP of Cx37À/À mice in response to Ang II is associated with increased levels of Ang II type 2 receptors in their aortas, with selective changes in the transcript levels of proteins involved in the Ang II signaling, including SHP-1 and CNKSR1, and with an altered phosphorylation of downstream targets of this signaling pathway (MLC2, ERK, and AKT). The data provide direct evidence that Cx37 plays a crucial, selective role in the control of Ang II-dependent hypertension.
Methods
The data, analytic methods, and study materials will be available to other researchers, for purposes of reproducing the results or replicating the procedure, on request from the Department of Medicine, Lausanne, Switzerland.
Animals and Surgery
Experiments were performed using 2-to 3-month-old Cx37À/À males (a kind gift from Dr A. Simon), 20 and WT littermate mice, all on a C57BL/6J genetic background. These mice were generated by breeding heterozygote Cx37+/À males and females. WT, heterozygous, and knockout animals were identified by polymerase chain reaction of genomic DNA, using the following primers: forward primer 5 Control mice were similarly implanted with pumps containing only 0.9% NaCl. WT and Cx37À/À mice were also treated with N x -Nitro-L-arginine methyl ester hydrochloride (L-NAME; Sigma-Aldrich Chemie GmbH, Buchs, Switzerland), which was added at the concentration of 500 mg/L to the drinking water, for 4 weeks. 6, 12, 23 Animal Monitoring
Systolic blood pressure (SBP) was measured on conscious mice by a noninvasive, computerized tail-cuff method (BP-2000, Visitech Systems). Mice were pretrained during 7 days, and thereafter pulse rate and BP were recorded by an automatic system of cuff inflation and deflation, over at least 15 days. 7, 9 At the end of the experience, blood samples (300 lL) were collected from the tail vein into EDTA-coated tubes. Plasma was separated by centrifugation at 4°C (8 minutes, 5720g), and stored at À80°C. Five microliters of plasma diluted in 100 lL 0.9% NaCl were incubated for 90 minutes at 37°C. Plasma from bilaterally nephrectomized male rats served as substrate for renin. Plasma renin concentration (PRC) was determined by measuring the capacity of plasma samples to generate AngI in the presence of an excess renin substrate. The generated angiotensin I (ng/mLÁh
À1
) was determined by radioimmunoassay (Byk&DiaSorin Diagnostics, Dietzenbach, Germany). 24 
Clinical Perspective
What Is New?
• We submitted Connexin37 (Cx37)-null mice to different models of angiotensin II (Ang II)-dependent and -independent hypertension, and document that Cx37 selectively participates in Ang II-mediated hypertension.
• In the renin-dependent model, Cx37À/À mice rapidly recover a normal blood pressure, in spite of increased plasma renin levels.
• This response results from an altered expression of proteins implicated in the Ang II pathway, notably AT2R.
What Are the Clinical Implications?
• Our data suggest the following scenario for the involvement of vascular Cx37 in the control of Ang II-dependent hypertension: in the absence of Cx37, increased aortic levels of AT2R and of downstream targets of the AT2R-dependent pathway associate to reduce the vasoconstrictive effects mediated by Ang II, eventually altering the development of hypertension.
• Understanding how AT2R is upregulated in the absence of Cx37 may help in developing new therapeutic tools against hypertension.
RNA and Protein Analysis
Mice were anesthetized with isoflurane, euthanized by cervical dislocation, and then depleted of blood by an intracardiac perfusion of 5 mL PBS. After PBS washing, aortas and kidneys were carefully removed, immersed into liquid nitrogen, reduced to powder, and stored at À80°C. For reverse transcription polymerase chain reaction analysis, the aortic and renal powders were homogenized in Tripure Isolation Reagent (Roche, Switzerland), and total RNA was extracted according to the manufacturer's instructions. RNA was analyzed by real-time quantitative polymerase chain reaction, using the primers given in Table 1 , and visualized using a supercooled CCD camera (Chemidoc XRS, Bio-Rad Laboratories). Densitometric analysis was performed using ImageLab Software (3.0.1 BioRad Laboratories). For immunolabeling, freshly excised kidneys and aortas were rapidly frozen and processed for cryosectioning. [5] [6] [7] 9 Cryostat sections were stained using 1 of the following antibodies: goat polyclonal antibodies against renin (R and D, AF4277), rabbit polyclonal against Cx40 (Chemicon, AB1726), Cx37 (Biotrend Chemikalien, Cx37A11-A) or Cx43 (Cell Signaling, 3512S). All antibodies were diluted 1:100. Primary antibodies were detected using antibodies to rabbit immunoglobulins labeled with AlexaFluor 488 or to goat immunoglobulins labeled with AlexaFluor 350 (Invitrogen), all diluted 1:500.
Statistical Analysis
Values are given as means+SEM in all bar graphs, and as meansAESEM in Table 2 . Mean values of different groups were compared by Student t test or 2-way ANOVA, and the Figure 1 . Loss of Cx37À/À alters the increase in blood pressure in models of renin-dependent hypertension. A, WT mice receiving daily 1 mg Ang II/kg body weight displayed a 50% increase in systolic blood pressure (SBP). Under the same conditions, Cx37À/À mice displayed a significantly lower increase of SBP. WT NaCl N=5; Cx37À/À NaCl, WT Ang II (angiotensin II), Cx37À/À Ang II N=6. B, Similar observations were made in mice receiving daily 0.25 mg Ang II/kg body weight WT NaCl, Cx37À/À NaCl N=7; WT Ang II, Cx37À/À Ang II N=8. C, Two weeks after the 2K1C (2-kidney, 1-clip) procedure, Cx37À/À mice also showed a lower increase in SBP than WT controls. WT sham (sham-operated controls) WT 2K1C, N=5; Cx37À/À sham, Cx37À/À 2K1C N=6. D, In contrast, both types of mice became similarly hypertensive after a treatment with L-NAME (N-nitro-L-arginine-methyl-ester); N=6. ***P≤0.001 vs corresponding controls (NaCl-infused or sham-operated animals);°°°P≤0.001 vs WT mice, as given by 2-way ANOVA of AUC (areas under the SBP curve). Ang II indicates angiotensin II; Cx37, connexin37; WT, wild type.
Results

Loss of Cx37 Attenuates the Increase in Blood Pressure Induced by Ang II
Basal SBP was similar in WT and Cx37À/À mice ( Figure 1 and Table 2 ). A systemic, 2-week-long infusion of NaCl did not alter the SBP of control WT and Cx37À/À mice ( Figure 1A ). In contrast, the daily infusion of 1 mg Ang II/kg body weight markedly increased (P<0.001) SBP in both types of animals ( Figure 1A ), even though this increase was significantly lower (P<0.001) in Cx37À/À than WT mice ( Figure 1A ). Infusion of a lower dose of Ang II (0.25 mg/kg body weight) revealed a comparable difference between the 2 types of mice, in spite of a modest increase in SBP ( Figure 1B ). During the first 2 weeks following the 2K1C surgery, known to induce a renin-dependent hypertension, SBP was also increased in both WT and Cx37À/À mice and, again, this increase was lower (P<0.001) in the latter than in the former mice ( Figure 1C ). In contrast, such a difference was not observed after an L-NAME treatment, known to induce a reninindependent hypertension ( Figure 1D ). The data suggest a selective role of Cx37 in the control of Ang II-dependent pathways.
Sustained Clipping of the Renal Artery Did Not Alter SBP of Cx37À/À Mice Four weeks after the 2K1C surgery, SBP remained significantly higher than control values in WT mice (Table 2 and Figure 2A ). In contrast, SBP of Cx37À/À mice had returned to the levels observed in sham-operated controls (Table 2 and Figure 2A) , documenting that the hypertension observed immediately after the 2K1C procedure ( Figure 1C ) was transient. A 4-weeklong, daily infusion of 0.25 mg Ang II/kg body weight also increased SBP significantly less (P<0.001) in Cx37À/À than in WT mice ( Figure 2B ), whereas an L-NAME treatment of the same duration had a similar hypertensive effect (P<0.001) in both types of mice ( Figure 2C) .
Evaluation of the organs obtained 4 weeks after the 2K1C surgery revealed the anticipated decrease in the relative weight index of the clipped kidney, and the associated increase in the relative weight of the unclipped kidney, in both WT and Cx37À/À mice, demonstrating that the 2K1C procedure similarly affected these organs in both types of animals (Table 2 ). However, the heart weight increased in the hypertensive 2K1C WT mice, but was not affected in Cx37À/À mice ( Table 2 ). The data document that, in the absence of Cx37, the modulation of hypertension because of the 2K1C procedure is transient, in spite of persistent renal effects of the surgery.
Accordingly, the levels of renin transcripts were similarly increased over control levels, in the clipped kidneys of both WT and Cx37À/À mice ( Figure 3A) . Parallel immunostaining of renin showed that the expression of this hormone increased in the hypoperfused kidneys of both WT and Cx37À/À 2K1C mice, and decreased in the unclipped, Figure 2 . Cx37À/À mice become rapidly normotensive after the 2K1C procedure. A, One month after the 2K1C surgery, WT mice were significantly hypertensive, compared with their sham-operated controls, whereas Cx37À/À mice featured a control SBP (systolic blood pressure). WT sham (shamoperated controls) N=15; Cx37À/À sham N=14; WT 2K1C (2-kidney, 1-clip) N=19; Cx37À/À 2K1C N=17. B, Compared with controls infused with NaCl, both WT and Cx37À/À mice showed a significant increase in SBP after a daily infusion of 0.25 mg Ang II/kg body weight during 1 month. However, this increase was significantly lower in Cx37À/À than in WT mice. WT NaCl, Cx37À/À NaCl N=7; WT Ang II (angiotensin II); Cx37À/À Ang II N=8. C, In contrast, the mice of these 2 genotypes showed a similar increase in blood pressure, after a daily treatment with L-NAME (N-nitro-L-arginine-methylester, 500 mg/L in the drinking water) for 1 month. N=6. Results are means+SEM. *P≤0.05 and ***P≤0.001 vs respective control mice;°°°P ≤0.001 vs WT mice, as given by 2-way ANOVA. Ang II indicates angiotensin II; Cx37, connexin37; n.s., not significant; WT, wild type.
contralateral kidneys of the very same animals ( Figure 3C ), still was higher in the kidneys of Cx37À/À than of WT mice. Consistent with these observations, the concentration of circulating renin was significantly higher in the plasma of Cx37À/À than in WT mice, in both the sham-operated mice and in the mice that were subjected to the whole 2K1C procedure ( Figure 3B ). The data document that, while the transcriptional expression of renin was similarly modulated by the 2K1C procedure in the kidneys of WT and Cx37À/À mice, the latter animals featured a higher renal content and plasma secretion of the hormone.
Cx37 Participates in Controling Ang II Signaling in Aortas
To investigate the mechanism associated with the reduced effect of Ang II in Cx37À/À mice, we studied the expression of transcripts coding for proteins involved in Figure 3 . Renin expression and secretion are increased by the 2K1C surgery in both WT and Cx37À/À mice. A, Four weeks after surgery, the basal levels of the renin transcript increased in the clipped, hypoperfused kidney of both WT and Cx37À/À mice. WT sham (sham-operated controls) N=14; Cx37À/À sham N=13; WT 2K1C N=16; Cx37À/À 2K1C N=12. B, The plasmatic concentration of renin (PRC) was also significantly increased in the 2 types of mice. However, Cx37À/À mice had basal and 2K1C-induced levels of PRC significantly higher than WT animals. WT sham N=8; Cx37À/À sham N=6; WT 2K1C (2-kidney, 1-clip) N=9; Cx37À/À 2K1C N=6. Results are means+SEM. *P≤0.05, ***P≤0.001 vs respective control mice;°P≤0.05,°°°P≤0.001 vs WT mice, as given by 2-way ANOVA. C, Renin immunostaining (green) increased in the hypoperfused left kidney of both WT and Cx37À/À mice, while decreasing in their contralateral right kidney, and was higher in Cx37À/À than in WT mice. Cx40 (Connexin40). Immunostaining (red) localizes the renin-secreting cells of the afferent arterioles. Bar=50 lm. AngI indicates angiotensin I; WT, wild type. the renin-angiotensin system. The renal levels of the transcripts coding for the angiotensin-converting enzymes (ACE and ACE2) were similar in WT and Cx37À/À mice, under both basal conditions and following the 2K1C surgery ( Figure 4 ). The transcript levels coding for angiotensinogen and the angiotensin receptors Agtr1a and Agtr1b were also similarly expressed in the aortas of WT and Cx37À/À mice ( Figure 5 ), and this was also the case for the cognate AT1R protein ( Figure 6A , 6B, and 6D). In contrast, the aortic levels of Agtr2 transcripts and of the cognate AT2R protein were higher in Cx37À/À than of WT mice ( Figures 5 and 6A, 6C , and 6E). The expression of both ATR1 and ATR2 proteins was not significantly altered in the aortas of Cx37À/À mice, after either the 2K1C surgery or the infusion of Ang II ( Figure 6 ).
The levels of transcripts coding for downstream proteins contributing to the AT2R-dependent pathway, including the AT2R-associated protein CNKSR1 (Cnksr1), 25 the AT2R
downstream tyrosine phosphatase SHP-1 (Ptpn6), 26 and the glutamyl aminopeptidase A (Enpep) converting Ang II to Ang III, 27 were also significantly higher in the aortas of Cx37À/À than of WT mice ( Figure 5 ). In contrast, the mRNA expression of several other signaling proteins of the Ang II pathway, including MAS1 (Mas1) the receptor for Ang-(1-7), which is known to promote vasodilation, 28,29 the chymase (Cma1), which catalyzes the Ang I-cleavaged to Ang II, 30 RGS2 (Rgs2), which negatively regulates the signaling by the G protein subunits of AT1R, 31 and DUSP1 (Dusp1), 32 an AT2R-downstream phosphatase involved in the AT2R-dependent ERK 1/2 dephosphorylation, was unaltered ( Figure 7 ). To decipher whether these modulations altered the Ang IImediated response, freshly isolated WT and Cx37À/À mice aortas were exposed to 40 lmol/L Ang II during 2 hours. This exposure increased the phosphorylation levels of the ERK ( Figure 8A ), MLC2 ( Figure 8B ), and AKT proteins ( Figure 8C ) in aortas of WT, but not in those of Cx37À/À mice. Collectively, these data document that the regulation of the Ang II pathway is selectively altered in mice lacking Cx37.
Loss of Cx37 Alters the Basal Expression of Aortic Cx43 and the Expression of Vascular Connexins After the 2K1C Surgery
To determine whether the loss of Cx37 altered the expression of the other vascular connexins, we analyzed aortic extracts by Western blots. We found that the loss of Cx37 did not affect the basal, control levels of Cx40 and Cx45, but significantly increased those of Cx43 (Figure 9 ). Four weeks after the 2K1C surgery, the levels of Cx37, Cx40, and Cx43 were significantly increased in the aortas of WT mice ( Figure 9A through 9C and 9E) , whereas those of Cx45 were unchanged ( Figure 9D ). Under the same conditions, the aortas of Cx37À/À mice shown unchanged levels of Cx40, and decreased levels of Cx43 and Cx45 ( Figure 9B through   9D and 9E). The data document that loss of Cx37 specifically affects aortic Cx43, and altered its modulation under conditions of Ang II-dependent hypertension. Figure 6 . Loss of Cx37 selectively alters the expression of the AT2 receptors in the aortas of Cx37À/À mice. A, Immunofluorescence showed a similar staining for AT1R (upper panels) in the aortas of all WT and Cx37À/À mice. In contrast, the staining for AT2R was more intense in the aortas of Cx37À/À than in WT mice. Bar=20 lm. L indicates lumen; M, media. B, Western blot showed that the aortas of WT and Cx37À/ À mice expressed similar levels of the AT1R protein. C, In contrast, the basal levels of the AT2R protein were higher in Cx37À/À than in WT mice, and were not increased after the 2K1C surgery. WT sham N=21; Cx37À/À sham N=17; WT 2K1C N=19; Cx37À/À 2K1C N=17. D and E, Comparable observations were made for both AT1R (D) and AT2R (E) in mice infused daily with 1 mg Ang II/kg body weight WT NaCl N=4; Cx37À/À NaCl, Cx37À/À Ang II N=3, WT Ang II N=6. Results are means+SEM.°P≤0.05 vs WT mice, as given by 2-way ANOVA. 2K1C indicates 2-kidney, 1-clip; AngII, angiotensin II; AT1R, Ang II type 1 receptors; AT2R, Ang II type 2 receptors; Cx37, Connexin37; DAPI, 4 0 ,6-diamidino-2-phenylindole; Sham, shamoperated controls; WT, wild type.
Loss of Cx37 Does Not Affect the Expression and Activation of Aortic eNOS
Since Cx37 directly interacts with eNOS, 19 we evaluated the aortic levels of this enzyme. Western blots showed that these levels were similar in WT and Cx37À/À mice, under both basal conditions, and 4 weeks after the 2K1C procedure ( Figure 10A ). Similar observations were made with regard to the active, phosphorylated form of eNOS ( Figure 10B ). The data do not support a participation of the eNOS pathway in the altered regulation of blood pressure in Cx37À/À 2K1C mice.
Discussion
Previous studies have documented the participation of Cx43, Cx40, and Cx37 in different models of hypertension. 3, [5] [6] [7] 9 While the role of the 2 former connexins has been understood by multiple studies of different research groups, 2,6,7,9,13,14,33 the involvement of the latter has been the topic of fewer studies, [6] [7] [8] 15, 34 and remains to be fully validated. Here, we provide direct evidence that Cx37 is selectively involved in the control of renin-dependent hypertension, via a mechanism that implicates its control of several proteins key to the Ang II-dependent pathway. Thus, loss of Cx37 did not alter the hypertension induced by a treatment with L-NAME, but reduced the hypertension induced by either an infusion of Ang II or a 2K1C surgery, 2 conditions that cause a marked renin-dependent hypertension in control mice.
Our data document that this reduction did not result from a defective renin or eNOS production in the animals lacking Cx37, but involved the specific increased expression of AT2 receptors. In this setting, we observed selective alterations in the signaling pathway elicited by Ang II. Thus, loss of Cx37 did Figure 7 . Loss of Cx37 does not alter the expression of several signals involved in the Ang II effects. The levels of transcripts coding for the chymase (Cma1), which converts Ang I to Ang II, the Regulator of G-protein signaling 2 (Rgs2), which negatively regulates AT1R function by modulating its Gaq subunit activity, the Dual specificity protein phosphatase 1 (Dusp1), an AT2R-associated phosphatase that contributes to AT2R-mediated inactivation of the ERK cascade, and Mas1, the receptor for Ang-(1-7) that promotes vasodilatation, were similar in the aortas of WT and Cx37À/À mice. WT N=9; Cx37À/À N=8. Results are means+SEM. Statistical analysis was performed using t test. Ang indicates angiotensin; AT1R, Ang II type 1 receptors; AT2R, Ang II type 2 receptors; Cx37, Connexin37; WT, wild type. not modify the expression of AT1 receptors, but increased that of AT2 receptors. Previous studies have shown that AT1 receptors are responsible for the vasoconstrictive effect of Ang II, which markedly contributes to hypertension, [35] [36] [37] [38] [39] whereas AT2 receptors antagonize this effect by promoting a vasodilation that counteracts hypertension. [40] [41] [42] [43] [44] Indeed, it was demonstrated that loss of AT2 receptors in mice resulted in a hypertension that associated with increased vasopressor response to Ang II. 45 Accordingly, a SMC-specific overexpression of AT2R in transgenic mice abolished the vasoconstrictive effect elicited by Ang II. 46 These data document for the first time that the upregulated expression of AT2 receptors observed in Cx37À/À mice at least partially accounts for the mitigated hypertension that these mice developed when exposed to either an infusion of Ang II or to the 2K1C surgery. The molecular mechanism whereby increased AT2R expression may prevent an overt and chronic hypertension Figure 9 . Loss of Cx37 alters the basal expression of aortic Cx43, and protects against the overexpression of Cx40 and Cx45 after the 2K1C procedure. A, Four weeks after the 2K1C procedure, Western blots showed a marked increase of Cx37 levels in the aortas of the WT mice that had become hypertensive. WT sham N=9; Cx37À/À sham N=7; WT 2K1C N=9; Cx37À/À 2K1C N=11. B, The levels of Cx40 were also increased in the aortas of WT made hypertensive, but not in Cx37À/À mice. WT sham N=18; Cx37À/À sham N=15; WT 2K1C N=16; Cx37À/À 2K1C N=14. C, The levels of Cx43 were enhanced in response to a renin-dependent model of hypertension (WT 2K1C). Cx37-deficient mice also displayed elevated Cx43 protein levels, which decreased after the 2K1C procedure. WT sham N=17; Cx37À/À sham N=13; WT 2K1C N=14; Cx37À/À 2K1C N=17. D, Comparable levels of Cx45 were evaluated in the aortas of control WT and Cx37À/À mice. After the 2K1C surgery, these levels did not change in the aortas of WT mice, but decreased in those of Cx37À/À mice. WT sham N=9; Cx37À/À sham N=7; WT 2K1C N=9; Cx37À/À 2K1C N=11. Results are means+SEM. *P≤0.05, **P≤0.01 vs respective control mice;°°P≤0.01,°°°P≤0.001 vs WT mice, as given by 2-way ANOVA. E, After the 2K1C surgery, the immunostaining of Cx40 (upper panels) was increased between the aortic EC of WT, but not of Cx37À/Àmice. Analogous changes were seen with regard to the immunostaining of Cx43 (middle panels) between the SMC of the media. The immunostaining of Cx37 (lower panels) increased in the aortic media of WT mice after the 2K1C surgery. L indicates lumen; M, media; Bar=20 lm. 2K1C indicates 2-kidney, 1-clip; Cx37, Connexin37; Cx40, Connexin40; Cx43, Connexin43; Cx45, Connexin45; EC, endothelial cells; Sham, sham-operated controls; SMC, smooth muscle cells; WT, wild type.
remains to be fully elucidated. Although the bradykinin/NO/ cGMP vasodilator cascade is the main downstream pathway responsible for the AT2R-mediated vasodepressor effect, we did not observe altered aortic levels of eNOS and P-eNOS in Cx37À/À mice. In contrast, we found that Cx37À/À mice displayed an increased expression of the transcripts coding for SHP-1 (Ptpn6), an important protein tyrosine phosphatase downstream of AT2R and known to induce an SLK-mediated RhoA phosphorylation, which inhibits RhoA-dependent arterial contraction and promotes vasodilation. 26 Accordingly, we also found that the phosphorylation-dependent activation of the myosin light chain 2 (MLC2), which is responsible for SMC contraction in arteries, was not induced by Ang II in the aortas of Cx37À/À mice. Consistent with these results, we further document that, after an Ang II stimulation, loss of Cx37 altered the phosphorylation of ERK and AKT, 2 other main downstream targets of AT1 receptors. Other proteins may be involved in the dysregulation of the Ang II pathway, inasmuch as we also found that loss of Cx37 increased the mRNA expression of CNSKR1, the connector enhancer of kinase suppressor of RAS 1, and of glutamyl aminopeptidase A. Full validation of this conclusion now calls for further experiments (eg, in the presence of antagonists and agonists of the AT2 receptors). Similar experiments could similarly target AT1 receptors to exclude a plausible alteration in their sensitivity. Eventually, our data also revealed that loss of Cx37 is associated with a significant, selective increase in the expression of Cx43 in SMC. This connexin allows for the rapid diffusion of calcium-dependent contraction waves between SMCs, modulating the vasomotor tone 16, 17 which, in turn, is key for the development and maintenance of reninand Ang II-dependent hypertension. 6, 7, 9, 14, 23, 33 The specific role that may be played by this connexin in the context of Cx37À/À mice exposed to hypertensive conditions remains to be elucidated in future studies. Even though the expression of Cx37, Cx43, and Cx40 5, 6, 8, 9, 12, 47 is usually coordinated, a contribution of the latter connexin appears unlikely in this context, inasmuch as Cx40 is not expressed in the SMCs of either normotensive or hypertensive mice, 3, 6, 7, 9, 10, 14 and its vascular levels were not altered after loss of Cx37À/À. 8 In summary, our findings document that loss of Cx37 partly protects against the development of Ang II-dependent hypertension, because of a selective increase in the expression of AT2R and of some of the downstream effectors involved in the signaling elicited by this form of Ang II receptors, notably SHP-1. Even though the molecular mechanism whereby the loss of Cx37 induces these alterations remains to be fully unraveled, these findings highlight a so far unsuspected, specific role of Cx37 in the control of the Ang II signaling pathway, setting the first, obligatory in vivo basis to now envisage further analyses to fine-tune the mechanistic scenario drafted here.
